Search

You searched for "consent"

901 results found
Cystisis Unmasked book cover image.

Cystitis Unmasked

5 October 2021 | URO - Infection, URO - Functional / Reconstructive Urology
Cystitis is often viewed as a heartsink diagnosis, and sometimes one of exclusion. The aetiology is multifactorial and misunderstood. Treatment has been based on dogma, and poor clinical and scientific evidence. The truth is, that despite the significant morbidity caused...
Prostate Cancer and Prostatic Diseases cover image.

ASAP: is a repeat biopsy necessary?

1 May 2016 | | URO - Urologic Oncology
This study examined the validity of current US and European guidelines on the management of patients diagnosed with atypical small acinar proliferation (ASAP). Current guidance states that these patients should undergo repeat biopsy within three to six months due to...

RSM: Trauma and On-call Urology

16 October 2026
Join the Royal Society of Medicine (RSM) Urology Section for this one-day meeting exploring trauma, emergency urology and the evolving landscape of urgent urological care. Bringing together leading specialists in urology, trauma surgery, interventional radiology and service transformation, the programme will examine the practical challenges of managing acute and high-pressure clinical situations across emergency and on-call settings.

RSM: Urothelial cancer: advances, innovation and improving outcomes

16 April 2027
Join the Royal Society of Medicine (RSM) Urology Section for this one-day meeting exploring the latest advances in urothelial cancer care. Bringing together leading urologists, oncologists and researchers, the programme will examine developments across the bladder cancer pathway, from diagnosis and transurethral resection of bladder tumour (TURBT) to bladder-sparing treatments, robotic surgery and new systemic therapies.

Virtual and augmented reality in surgery

1 January 2018 | | URO - Technology
Virtual reality (VR) is a three-dimensional, computer generated environment which can be accessed using a virtual reality headset, allowing individuals to immerse themselves in this virtual world. Augmented reality (AR) systems layer virtual information over a live camera feed into...

The role of transperineal template biopsies in the diagnosis of prostate cancer

1 March 2014 | | URO - Urologic Oncology
The case In 2002, Mr A, a 64-year-old software engineer, was referred by his GP for further investigation of a raised prostate specific antigen (PSA) of 6.2. His prostate felt benign. He underwent transrectal ultrasound guided (TRUS) prostate biopsies. This...

Urologic complications of radiotherapy

1 July 2014 | | URO - Urologic Oncology
Case 1 1. What machine is seen in the picture? 2. What is the standard dose schedule for radiotherapy for prostate cancer? 3. What are the complications of radiotherapy? Case 2 1. How does haemorrhagic cystitis develop? 2. What are...

Demanding cases or nightmares in uro-oncology? Sep/Oct 2021

3 September 2021 | | URO - Urologic Oncology
Active surveillance for prostate cancer: missing the boat Case In 2005 a 43-year-old man of Afro-Caribbean ethnicity was referred to our centre for investigation of suspected prostate cancer. Digital rectal exam revealed a firm right lobe, PSA of 2.3ng/ml, prostate...

The doctor as the patient: receiving bad news

13 March 2023 | URO - Urologic Oncology
This article, written by a GP working in the NHS, gives a unique insight into the experience of being a urology patient and some thoughtful advice on ‘breaking bad news’. Day 1 Alarm bells ring. It’s spotting an email from...

Bladder cancer – an overshadowed ‘volcano’

1 May 2015 | | URO - Urologic Oncology
Bladder cancer has often been overshadowed by the limelight of prostate cancer. However, of all the urological cancers, bladder cancer is the only one which has shown a slight decline in age-standardised five-year survival rates over the last couple of...

Endoscopic management of upper tract urothelial carcinoma

1 January 2014 | | URO - Urologic Oncology
Upper tract urothelial carcinoma (UTUC) is a rare disease accounting for 5-10% of all urothelial carcinomas and has an annual incidence in Western countries of 1-2 per 100,000 [1,2]. It occurs more commonly in the pelvicalyceal system as opposed to...

Obesity and Urologic cancers: A student’s perspective on risk, systems and surgical implications

7 May 2026 | | URO - Urologic Oncology
During my clinical placements, I began to notice that some patients did not fit neatly into the scenarios we learned about in lectures. One patient in particular had a raised PSA and several comorbidities, including obesity. What stood out was...